CalAmp Corp. (CAMPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0700
+0.0300 (75.00%)
Inactive · Last trade price on Jul 31, 2024
CalAmp Employees
CalAmp had 644 employees as of February 28, 2023. The number of employees decreased by 243 or -27.40% compared to the previous year.
Employees
644
Change (1Y)
-243
Growth (1Y)
-27.40%
Revenue / Employee
$411,081
Profits / Employee
-$157,377
Market Cap
120.57K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Feb 28, 2023 | 644 | -243 | -27.40% |
| Feb 28, 2022 | 887 | -96 | -9.77% |
| Feb 28, 2021 | 983 | -97 | -8.98% |
| Feb 29, 2020 | 1,080 | 198 | 22.45% |
| Feb 28, 2019 | 882 | 42 | 5.00% |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
CalAmp News
- 22 days ago - CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - GSK Deal Is Key Validation For CAMP4's Drug Discovery Platform: Analyst - Benzinga
- 7 weeks ago - CAMP4 Therapeutics Teams With GSK On ASO Drug Candidates - Nasdaq
- 7 weeks ago - CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries - GlobeNewsWire
- 2 months ago - CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire